If Cannabis Helps Sleep, Why Does Science Say It Doesn’t?

Cannabis has long been touted as an insomnia cure, but many experts say it’s not a viable long-term sleep solution for insomniacs. Although plenty has been written about cannabis and insomnia, millions of users — and their doctors — are left in the dark as more states legalize cannabis for both recreational and medicinal use, flooding the market with sugary edibles, pungent oils, and more.

The Gap Between Perception and Proof

While research on this topic is in its infancy, one thing is clear: weed may not be the cure for insomnia that culture makes it out to be. But as weed becomes more and more mainstream, the public is being subjected to a massive health experiment, one in which anecdotal reports of relief from insomnia using weed are increasingly trumping out higher quality data in the medical literature regarding the use of weed for treatment of insomnia.

Why It Matters

The Clinical and Systemic Stakes

While sleep is one of the most natural functions of the body, it is also one of the most critical to our health and wellbeing. So many of our other health issues are affected by our sleep, including our heart health, cognitive function and our ability to regulate our emotions. Many of us are trying to get better sleep, and are seeking out sleep solutions to help us get through the night. Cannabis is often considered a simple sleep solution for many. The variety of products available to consumers including flower, oils, sweets like gummy bears and vape products can make it an appealing option for sleep. About 30% of the global population report symptoms of insomnia.

The Disconnect in Evidence

You may be surprised to learn that most clinicians do not know that this misconception exists. But there is a serious cost to clinical ignorance of this misconception. For instance, assuming that cannabis helps people sleep can interfere with patient’s receipt of timely evidence-based treatment for sleep problems, including the established and effective treatment for insomnia: Cognitive Behavioral Therapy for Insomnia (CBT-I).

In addition to finding evidence of a placebo effect in the cannabis studies it evaluated, the review found many study participants reported improved sleep. However, measurements using polysomnography (a monitor that tracks sleep stages throughout one night) found small or no differences in sleep duration and quality between participants treated with cannabis and those who received a placebo.

Operational and Safety Risks

In addition to consequences for the individual user, the difference between product labels and labeled active ingredients at the “dose per unit” measure has implications for the system as a whole—namely, for regulators and for payers. A patient using a high-THC product for sleep might experience morning after effects of decreased processing speed, decreased memory, and decreased motor speed, which could impair his or her ability to safely operate a vehicle or go to work. Of greater concern are the possible drug interactions resulting from the effects of cannabis on the cytochrome P450 enzymes, which are metabolized by the liver and affect the metabolism of many commonly prescribed medications, including anticoagulants and antidepressants.

Who It Affects

The Patient Profiles

There are the people with chronic insomnia or poor sleep who are most visible to others and then there are:

• The Aging Population: Older adults seeking alternatives to “Z-drugs” (like zolpidem) due to fears of falls or dementia.
• Shift Workers: Individuals struggling with circadian rhythm disruptions.
• Patients with PTSD: Those using cannabis to suppress nightmares, though long-term data suggest this may lead to “REM rebound” and worsened symptoms upon cessation.

Cannabis for sleep is a very popular topic, partly due to people either having tried prescription sleep aids and found them ineffective or having refused them for various reasons, possibly due to the perception that cannabis is a “cleaner” alternative, whatever that means to the individual. A trial funded under ESOP, “ESOP-Sleep”, recently investigated the perceived sleep inducing effects of a THC/CBD/CBN based oil over a period of 12 weeks compared to a placebo oil. Participants’ Insomnia Severity Index (ISI) scores did not indicate any improvement.

The Burden on Clinicians

Healthcare professionals from primary care to psychiatry to neurology and sleep medicine are facing a unique conundrum as they struggle to stay up-to-date on the array of cannabis-based products and substances hitting the market. While some substances have been declared legal for recreational or medical use at the state level, they remain classified as Schedule I or III substances under federal law, causing frustration and confusion for those in the medical field. But perhaps most confounding is the issue of proper dosing. What does it mean to say “to recommend one gummy” when the next product down the street with a similar label may contain a completely different balance of psychoactive and non-psychoactive cannabinoids?

Health Systems and Payers

A significant percentage of a health system’s patient registry uses cannabis for sleep. Now, systems and procedures need to be put in place to accurately document and screen for use. Providers and payers are deciding whether or not to cover evidence-based and expensive CBT-I as a safer treatment for chronic insomnia compared to cannabis, or to stay out of it as the user base continues to grow.

What Changes

A New Framework for Clinical Practice

What’s old is new again, because the medical use of cannabis is not just about pain relief anymore.

1. From Anecdote to Inquiry: Clinicians should treat reports of cannabis use as a clinical question. Instead of nodding along, they should ask: What is the THC-to-CBD ratio? Are you using an edible or a combustible? How do you feel at 10:00 AM the next day?
2. Tiered Treatment Pathways: Cannabis should never be a first-line therapy. The gold standard remains CBT-I. If a patient insists on cannabis, it should be managed as a monitored trial with clear stop rules if sleep does not objectively improve within 4 weeks.
3. Standardization Requirements: The industry needs to move toward pharmaceutical-grade transparency. This includes third-party testing for heavy metals, pesticides, and exact cannabinoid concentrations.

The “Experience vs. Evidence” Gap: Why the Confusion?

Cannabis has become increasingly popular in recent years and, surprisingly, most scientific studies have found no benefits from its use. Yet there are millions of users who passionately attest to its medicinal, recreational, and spiritual benefits. How can we understand this phenomenon, given our typical assumptions about the relationship between scientific research and reality? Part of the answer lies in recognizing the distinction between subjective and objective ways of experiencing reality.

The Subjective “Win”

This is interesting because THC is such a strong muscle relaxer and anxiolytic for so many people. Even if sleep quantity or quality isn’t improving, people may report that they’re sleeping better because the cannabis is reducing their anxiety and making them feel less awake at times when they would normally be awake (i.e. during the day after waking up). In addition, THC has the potential to “knock you out” – meaning users feel like they’re sleeping when in reality they’re just in a state of sedation.

The Objective “Loss”

THC in cannabis decreases REM sleep which is essential for processing emotions and storing memories in long-term memory. After a period of heavy cannabis use, REM sleep is increased to make up for the lack of sleep (REM rebound). Initially, this results in a series of vivid and disturbing dreams that can plague a person for months or even years after they stop using cannabis. These terrible visions can cause a user to go back to the substance in order to calm their brain and stop the nightmares, creating a cycle of dependence.

Product Heterogeneity

The average cannabis user may not be aware that there is more to the plant than the familiar marijuana that they have come to know. But what they may not know, is that cannabis is a true polypharmacy, containing over 100 cannabinoids and hundreds of terpenes.